Market Research
Acuvue · Insights powered by ZoomRx
HCP Awareness76%+8%
Brand Preference62%+5%
Patient Satisfaction89%+12%
Prescriber Intent71%+3%
Key Findings
Strong HCP Recognition in Immunology
High Impact76% of surveyed rheumatologists can recall brand messaging without prompting, up from 68% in Q4 2025.
Patient Access Remains Top Concern
Critical Impact63% of patients cite insurance coverage and prior authorization as barriers to treatment initiation.
Digital Engagement Growing
Medium ImpactMobile app usage increased 34% quarter-over-quarter, with patient education modules most accessed.
Recent Studies
| Study Name | Status | Respondents | Date |
|---|---|---|---|
| HCP Awareness Study Q1 2026 | Completed | 450 | Apr 15 |
| Patient Journey Mapping | In Progress | 287 | Ongoing |
| Competitor Perception Analysis | Completed | 520 | Mar 28 |
| Brand Positioning Research | Scheduled | — | May 20 |